Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M104Revenue (TTM) $M15.5Net Margin (%)-431.9Altman Z-Score-10.6
Enterprise Value $M101EPS (TTM) $-1.3Operating Margin %-411.3Piotroski F-Score1
P/E(ttm)--Beneish M-Score-0.4Pre-tax Margin (%)-431.9Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio2.0Cash flow > EarningsY
Price/Sales5.55-y EBITDA Growth Rate %--Current Ratio2.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-86.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-948.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M54.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with BDSI

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BDSI is held by these investors:



BDSI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sirgo Mark APresident, CEO & Vice Chairman 2017-03-31Sell110,895$1.9-15.79view
De Paolantonio Ernest RobertCFO, Secretary and Treasurer 2017-03-23Sell170$1.9-15.79view
Vasisht NirajSVP & Chief Technology Officer 2017-03-23Sell530$1.9-15.79view
ODONNELL FRANCIS E JRDirector 2017-03-23Sell750$1.9-15.79view
Vasisht NirajSVP & Chief Technology Officer 2017-03-01Sell42,000$1.98-19.19view
De Paolantonio Ernest RobertSee Remarks 2017-03-01Sell19,750$1.97-18.78view
ODONNELL FRANCIS E JRDirector 2017-02-17Sell129,860$1.91-16.23view
Vasisht NirajSee Remarks 2017-01-30Sell6,905$1.91-16.23view
SEARS SAMUEL P JRDirector 2016-12-01Sell12,000$1.67-4.19view
Feinberg Barry IDirector 2016-11-23Buy2,000$1.67-4.19view

Quarterly/Annual Reports about BDSI:

News about BDSI:

Articles On GuruFocus.com
BioDelivery Sciences Announces the Granting of Two New Patents to be Listed in FDA's Orange Book Fur Mar 31 2017 
Weekly CFO Buys Highlight: BioDelivery Sciences International, TheStreet, Antares Pharma Mar 27 2016 
Weekly CEO Sells Highlight: Vringo Inc, Medivation Inc, BioDelivery Sciences International Inc and H Feb 02 2014 
Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX Jul 17 2012 
BioDelivery Sciences International Inc. Reports Operating Results (10-K/A) Nov 19 2010 
BioDelivery Sciences International Inc. Reports Operating Results (10-Q) Aug 09 2010 
BioDelivery Sciences International Inc. Reports Operating Results (10-Q) Aug 09 2010 
BioDelivery Sciences International Inc. (BDSI) CEO Mark A Sirgo buys 4,022 Shares Jun 10 2010 
BioDelivery Sciences International Inc. (BDSI) CEO Mark A Sirgo buys 4,450 Shares May 24 2010 
BioDelivery Sciences International Inc. Reports Operating Results (10-Q) May 10 2010 

More From Other Websites
BioDelivery (BDSI) Down 15% Since Earnings Report: Can It Rebound? Apr 18 2017
New cash, patents boost optimism at Raleigh's BioDelivery Sciences Apr 04 2017
BioDelivery to Grant New Patents for its Marketed Drugs Apr 03 2017
Blog Coverage BioDelivery Extends its Patent Portfolio; Acquires Extended Patents for BELBUCA,... Apr 03 2017
BioDelivery Sciences Secures Two Patents Mar 31 2017
BioDelivery Sciences Announces the Granting of Two New Patents to be Listed in FDA's Orange Book... Mar 31 2017
BioDelivery Sciences International and Rexahn Pharmaceuticals See Share Values Rise Slightly Mar 28 2017
BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet Mar 20 2017
Edited Transcript of BDSI earnings conference call or presentation 17-Mar-17 12:00pm GMT Mar 17 2017
BioDelivery Q4 Loss Wider Than Expected; Revenues in Line Mar 17 2017
BioDelivery reports 4Q loss Mar 17 2017
BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016... Mar 17 2017
BioDelivery Sciences Announces Three Data Presentations on BELBUCA® at the American Academy of Pain... Mar 16 2017
BioDelivery Sciences to Host Conference Call and Webcast Reporting Fourth Quarter and Full-Year 2016... Mar 09 2017
BioDelivery Sciences to Present at the 29th Annual ROTH Conference Mar 08 2017
Has Biodelivery Sciences Finally Turned the Corner? Mar 06 2017
BioDelivery (BDSI): What's in Store this Earnings Season? Mar 06 2017
Endo profit, sales beat as the drugmaker enters transition phase Feb 28 2017
BioDelivery Sciences Secures Debt Financing with CRG Feb 23 2017
Belbuca return expected to push BDSI to profitability sooner Feb 01 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)